Trial Profile
The randomized trial of Peginterferon alfa 2a or alfa2b with simeprevir and ribavirin for chronic hepatitis C
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 Apr 2014
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Peginterferon alfa-2b (Primary) ; Simeprevir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 Apr 2014 New trial record